Open AccessEffect of Vildagliptin on Hepatic Steatosis
Author(s) -
Mavin Macauley,
Kieren G. Hollingsworth,
Fiona E. Smith,
Peter E. Thelwall,
Ahmad Al-Mrabeh,
Anja Schweizer,
James E. Foley,
Roy Taylor
Publication year - 2015
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2014-3794
Subject(s) - vildagliptin , medicine , endocrinology , glycated hemoglobin , placebo , triglyceride , steatosis , type 2 diabetes , insulin , diabetes mellitus , metformin , cholesterol , alternative medicine , pathology
Although dipeptidyl-peptidase-4 inhibitors exert their major action via an incretin mechanism, a favorable effect of vildagliptin on lipid metabolism remains unexplained.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom